515
Views
3
CrossRef citations to date
0
Altmetric
Original

Alzheimer’s disease

Pages 173-185 | Received 03 Nov 2011, Published online: 07 Dec 2011

References

  • Amaral DG, Witter MP. The three-dimensional organization of the hippocampal formation: A review of anatomical data. Neuroscience 1989; 31: 571–591
  • Arnaiz E, Jelic V, Almkvist O, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuro Report 2001; 12: 851–855
  • Benson DF, Kuhl DE, Hawkins RA, et al. The fluorodeoxyglucose 18F scan in Alzheimer’s disease and multi-infarct dementia. Arch Neurol 1983; 40: 711–714
  • Bondi MW, Houston WS, Eyler LT, Brown GG. Fmri evidence of compensatory mechanisms in older adults at genetic risk for Alzheimer disease. Neurology 2005; 64: 501–508
  • Bookheimer SY, Strojwas MH, Cohen MS, et al. Patterns of brain activation in people at risk for Alzheimer’s disease. N Engl J Med 2000; 343: 450–456
  • Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol (Berl) 1991; 82: 239–259
  • Braak H, Braak E. Evolution of the neuropathology of Alzheimer’s disease. Acta Neurol Scand Suppl 1996; 165: 3–12
  • Burggren AC, Small GW, Sabb FW, Bookheimer SY. Specificity of brain activation patterns in people at genetic risk for Alzheimer disease. Am J Geriatr Psychiatry 2002; 10: 44–51
  • Cabeza R, Anderson ND, Locantore JK, McIntosh AR. Aging gracefully: Compensatory brain activity in high-performing older adults. NeuroImage 2002; 17: 1394–1402
  • Chetelat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: Can FDG-PET predict who is to rapidly convert to Alzheimer’s disease?. Neurology 2003; 60: 1374–1377
  • Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer’s disease in late onset families. Science 1993; 261: 921–923
  • de Leon MJ, Convit A, Wolf OT, et al. Prediction of cognitive decline in normal elderly subjects with 2-[18F]fluoro-2-deoxy-D-glucose/positron-emission tomography (FDG/PET). Proc Natl Acad Sci USA 2001; 98: 10966–10971
  • de Leon MJ, Golomb J, George AE, et al. The radio-logic prediction of Alzheimer disease: The atrophic hippocampal formation. AJNR Am J Neuroradiol 1993; 14: 897–906
  • de Toledo-Morrell L, Dickerson B, Sullivan MP, et al. Hemispheric differences in hippocampal volume predict verbal and spatial memory performance in patients with Alzheimer’s disease. Hippocampus 2000; 10: 136–142
  • Dickerson BC, Goncharova I, Sullivan MP, et al. MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease. Neurobiol Aging 2001; 22: 747–754
  • Dickerson BC, Salat DH, Bates JF, et al. Medial temporal lobe function and structure in mild cognitive impairment. Ann Neurol 2004; 56: 27–35
  • Eberling JL, Jagust WJ, Reed BR, Baker MG. Reduced temporal lobe blood flow in Alzheimer’s disease. Neurobiol Aging 1992; 13: 483–491
  • Flicker C, Ferris SH, Reisberg B. Mild cognitive impairment in the elderly: Predictors of dementia. Neurology 1991; 41: 1006–1009
  • Friedland RP, Budinger TF, Ganz E, et al. Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 1983; 7: 590–598
  • Goekoop R, Rombouts SA, Jonker C, et al. Challenging the cholinergic system in mild cognitive impairment: A pharmacological fMRI study. NeuroImage 2004; 23: 1450–1459
  • Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer’s disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci USA 2004; 101: 4637–4642
  • Grober E, Kawas C. Learning and retention in preclinical and early Alzheimer’s disease. Psychol Aging 1997; 12: 183–188
  • Helpern JA, Lee SP, Falangola MF, et al. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer’s disease. Magn Reson Med 2004; 51: 794–798
  • Higuchi M, Iwata N, Matsuba Y, et al. 19F and 1H MRI detection of amyloid β plaques in vivo. Nature Neurosci 2005; 8: 527–533
  • Jack Jr CR, Garwood M, Wengenack TM, et al. In vivo visualization of Alzheimer’s amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent. Magn Reson Med 2004; 52: 1263–1271
  • Jack Jr CR, Petersen RC, O’Brien PC, Tangalos EG. MR-based hippocampal volumetry in the diagnosis of Alzheimer’s disease. Neurology 1992; 42: 183–188
  • Jack Jr CR, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer’s disease. Neurology 1997; 49: 786–794
  • Jack Jr CR, Petersen RC, Xu Y, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 2000; 55: 484–489
  • Jacobs DM, Sano M, Dooneief G, et al. Neuropsycho-logical detection and characterization of preclinical Alzheimer’s disease. Neurology 1995; 45: 957–962
  • Jagust WJ, Budinger TF, Reed BR. The diagnosis of dementia with single photon emission computed tomography. Arch Neurol 1987; 44: 258–262
  • Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer’s disease using SPECT. Neurology 1998; 50: 1563–1571
  • Kantarci K, Jack Jr CR, Xu YC, et al. Mild cognitive impairment and Alzheimer disease: Regional diffusivity of water. Radiology 2001; 219: 101–107
  • Kantarci K, Petersen RC, Boeve BF, et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 2005; 64: 902–904
  • Kato T, Knopman D, Liu H. Dissociation of regional activation in mild AD during visual encoding: A functional MRI study. Neurology 2001; 57: 812–816
  • Klunk WE, Engler H, Nordberg A, et al. Imaging brain amyloid in Alzheimer’s disease with Pittsburgh Compound-B. Ann Neurol 2004; 55: 306–319
  • Leniger-Follert E, Hossmann KA. Simultaneous measurements of microflow and evoked potentials in the somatomotor cortex of the cat brain during specific sensory activation. Pflugers Arch 1979; 380: 85–89
  • Lorente de No R. Studies on the structure of the cerebral cortex II. Continuation of the study of the ammonic system. J Psychol Neurol 1934; 46: 113–117
  • Lustig C, Snyder AZ, Bhakta M, et al. Functional deactivations: Change with age and dementia of the Alzheimer type. Proc Natl Acad Sci USA 2003; 100: 14504–14509
  • Machulda MM, Ward HA, Borowski B, et al. Comparison of memory fMRI response among normal, MCI, and Alzheimer’s patients. Neurology 2003; 61: 500–506
  • Malonek D, Grinvald A. Interactions between electrical activity and cortical microcirculation revealed by imaging spectroscopy: Implications for functional brain mapping. Science 1996; 272: 551–554
  • Masur DM, Sliwinski M, Lipton RB, et al. Neuro-psychological prediction of dementia and the absence of dementia in healthy elderly persons. Neurology 1994; 44: 1427–1432
  • Mayeux R. Evaluation and use of diagnostic tests in Alzheimer’s disease. Neurobiol Aging 1998; 19: 139–143
  • Minoshima S, Giordani B, Berent S, et al. Metabolic reduction in the posterior cingulate cortex in very early Alzheimer’s disease. Ann Neurol 1997; 42: 85–94
  • Morris JC, Storandt M, Miller JP, et al. Mild cognitive impairment represents early-stage Alzheimer disease. Arch Neurol 2001; 58: 397–405
  • Mungas D, Reed BR, Jagust WJ, et al. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002; 59: 867–873
  • Ogawa S, Lee TM, Kay AR, Tank DW. Brain magnetic resonance imaging with contrast depen dent on blood oxygenation. Proc Natl Acad Sci USA 1990; 87: 9868–9872
  • Ogawa S, Tank DW, Menon R, et al. Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping using MRI. Proc Natl Acad Sci USA 1992; 89: 5951–5955
  • Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001; 58: 1985–1992
  • Petersen RC, Jack Jr CR, Xu YC, et al. Memory and MRI-based hippocampal volumes in aging and AD. Neurology 2000; 54: 581–587
  • Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 1999; 56: 303–308
  • Price JL, Morris JC. Tangles and plaques in nonde- mented aging and ‘preclinical’ Alzheimer’s disease. Ann Neurol 1999; 45: 358–368
  • Raichle ME, MacLeod AM, Snyder AZ, et al. A default mode of brain function. Proc Natl Acad Sci USA 2001; 98: 676–682
  • Rombouts SA, Barkhof F, Van Meel CS, Scheltens P. Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2002; 73: 665–671
  • Rombouts SA, Barkhof F, Veltman DJ, et al. Functional MR imaging in Alzheimer’s disease during memory encoding. AJNR Am J Neuroradiol 2000; 21: 1869–1875
  • Rombouts SA, Van Swieten JC, Pijnenburg YA, et al. Loss of frontal fMRI activation in early frontotempo-ral dementia compared to early AD. Neurology 2003; 60: 1904–1908
  • Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele ϵ4 with late-onset familial and sporadic Alzheimer’s disease. Neurology 1993; 43: 1467–1472
  • Saykin AJ, Wishart HA, Rabin LA, et al. Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 2004; 127: 1574–1583
  • Shoghi-Jadid K, Small GW, Agdeppa ED, et al. Localization of neurofibrillary tangles and β-amyloid plaques in the brains of living patients with Alzheimer disease. AmJ Geriatr Psychiatry 2002; 10: 24–35
  • Small SA. Age-related memory decline; current concepts and future directions. Arch Neurol 2001; 58: 360–364
  • Small SA. Measuring correlates of brain metabolism with high-resolution MRI: A promising approach for diagnosing Alzheimer disease and mapping its course. Alzheimer Dis Assoc Disord 2003; 17: 154–161
  • Small SA, Chawla MK, Buonocore M, et al. Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging. Proc Natl Acad Sci USA 2004; 101: 7181–7186
  • Small SA, Mayeux R. 2000. Delerium and dementia. In: Rowland LP (ed). Merritt’s Neurology, 10th edn. Philadelphia: Lippincott Williams & Wilkins. 3--6.
  • Small SA, Perera GM, DeLaPaz R, et al. Differential regional dysfunction of the hippocampal formation among elderly with memory decline and Alzheimer’s disease. Ann Neurol 1999; 45: 466–472
  • Small SA, Tsai WY, DeLaPaz R, et al. Imaging hippocampal function across the human life span: Is memory decline normal or not?. Ann Neurol 2002; 51: 290–295
  • Smith CD, Andersen AH, Kryscio RJ, et al. Women at risk for AD show increased parietal activation during a fluency task. Neurology 2002; 58: 1197–1202
  • Sperling RA, Bates JF, Chua EF, et al. fMRI studies of associative encoding in young and elderly controls and mild Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2003; 74: 44–50
  • Thulborn KR, Waterton JC, Matthews PM, Radda GK. Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 1982; 714: 265–270
  • Turner R, Le Bihan D, Moonen CT, et al. Echo-planar time course MRI of cat brain oxygenation changes. Magn Reson Med 1991; 22: 159–166
  • Vanhoutte G, Dewachter I, Borghgraef P, et al. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer’s disease. Magn Reson Med 2005; 53: 607–613
  • Wadghiri YZ, Sigurdsson EM, Sadowski M, et al. Detection of Alzheimer’s amyloid in transgenic mice using magnetic resonance microimaging. Magn Reson Med 2003; 50: 293–302

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.